title: Regulators deny access to experimental hepatitis C drug.
abstract: An application for access to an experimental hepatitis C drug under Canada's Special Access Programme has been turned down. In the process, Canada's drug regulators have created discomfort and uncertainty about how the Special Access Programme is managed.
authors.forename: Glen
authors.initials: G
authors.lastname: Hillson
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D002170:Canada; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D015507:Drugs, Investigational / Q000600:supply & distribution*; D006297:Health Services Accessibility; D006526:Hepatitis C / Q000188:drug therapy*
chemical_list: D000998:Antiviral Agents; D015507:Drugs, Investigational